Home

Ajanta Pharma Ltd EPS

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

EPS

₹ 71.88

Last updated on: Apr 03, 2025

Key Highlights

  • The Earning per Share of Ajanta Pharma Ltd is ₹ 71.88 as of 03 Apr 25 .
  • The earning per share of Ajanta Pharma Ltd changed from ₹ 16.53 to ₹ 18.6 over 7 quarters. This represents a CAGR of 6.97% .

Historical Earning per Share of Ajanta Pharma Ltd

No data available

* All values are in

Company Fundamentals for Ajanta Pharma Ltd

Market Cap

32,747 Cr

EPS

71.9

P/E Ratio (TTM)

36.5

P/B Ratio (TTM)

8.9

Day’s High

2703.25

Day’s Low

2612.05

DTE

0.0

ROE

23.8

52 Week High

3485.75

52 Week Low

2049.75

ROCE

32.1

Market Price of Ajanta Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Ajanta Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Apr 20252621.65
02 Apr 20252618.1
01 Apr 20252615.8
28 Mar 20252618.5
27 Mar 20252631.25
26 Mar 20252728
25 Mar 20252771.1
24 Mar 20252765.55
21 Mar 20252726.5
20 Mar 20252626.7

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Ajanta Pharma Ltd

Asset Value vs Market Value of Ajanta Pharma Ltd

Market Value

32,748

Asset Value

Value addition

11.7 X

2,570

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Ajanta Pharma Ltd32747
Sun Pharmaceutical Industries Ltd424706
Divis Laboratories Ltd152946
Cipla Ltd120751
Torrent Pharmaceuticals Ltd109983
Mankind Pharma Ltd100168

Historical Market Cap of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Ajanta Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Ajanta Pharma Ltd News Hub

Ajanta Pharma fixes record date for interim dividend

Ajanta Pharma has fixed 06 November 2024 as record date for payment of interim dividend, if declared

Read more

23 Oct 24

Ajanta Pharma Ltd eases for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2974.35, do

Read more

23 Oct 24

Ajanta Pharma to hold board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 October 2024. Power

Read more

17 Oct 24

Board of Ajanta Pharma recommends First Interim Dividend

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 28 October

Read more

28 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

May 2024

Transcript

Oct 2023

Transcript

July 2023

Transcript

May 2023

Transcript

Aug 2022

Transcript

FAQs for EPS of Ajanta Pharma Ltd

What is the EPS of Ajanta Pharma Ltd stock?

The Earnings Per Share (EPS) of Ajanta Pharma Ltd is 71.88. An EPS is the amount of net income attributed to each share of a common stock.

How is Ajanta Pharma Ltd EPS calculated?

The EPS of Ajanta Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ajanta Pharma Ltd report its EPS?

Ajanta Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ajanta Pharma Ltd EPS?

Factors that influence the EPS of Ajanta Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ajanta Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Ajanta Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions